Derek Miller
Member Board of Trustees @Blood Cancer United
Signup · Get unlimited contacts
WORK HISTORY
Member Board of Trustees @Blood Cancer United
EDUCATION
Villanova University
MBA, Marketing
University of Delaware
BA, Biology
SKILLS
ABOUT DEREK MILLER
At Aro Biotherapeutics, I was responsible for developing the corporate strategy, including corporate messaging, pipeline and technology platform strategies, business development, licensing, and investor activities. Prior to joining Aro, I held the position of Chief Business Officer for Celator Pharmaceticals, where I was responsible for developing and executing against Celator\'s Corporate Development Strategy and all aspects of the Commercial Strategy for the lead asset, VYXEOS, the development pipeline, and the CombiPlex technology platform. The strategy ultimately led to the successful exit, in which Celator was acquired for over $1.5 Billion. At Celator, I oversaw all Business Development activities, and was instrumental in all investor relations activities/financing activities, including confidentially marketed offerings totaling more than $60 Million.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.